Series A funding round for Code Biotherapeutics raising $75M in June 2022
Series A funding round for Code Biotherapeutics raising $75M in June 2022
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Ed Mathers |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$85M
Top Valuation
-
Code Biotherapeutics raised $75M in a Series A round.
The round was announced on 06/01/22.
The round was led by Northpond Ventures.